Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema

Pravin U. DugelArshad M. KhananiBrian B. BergerSunil PatelMitchell FinemanGlenn J. JaffePetra Kozma-WiebeJeffrey Heier

Journal: Translational Vision Science & Technology December 2021, Vol.10, 28.

Publication date: 
January, 2022